首页> 美国卫生研究院文献>Cancer Science >Impact of the p53 Status of the Tumor Cells on the Effect of Reactor Neutron Beam Irradiation with Emphasis on the Response of Intratumor Quiescent Cells
【2h】

Impact of the p53 Status of the Tumor Cells on the Effect of Reactor Neutron Beam Irradiation with Emphasis on the Response of Intratumor Quiescent Cells

机译:肿瘤细胞的p53状态对反应堆中子束辐照的影响并着重于肿瘤内静态细胞的反应

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Human head and neck squamous cell carcinoma cells transfected with mutant p53 (SAS/mp53) or with neo vector as a control (SASeo) were inoculated subcutaneously into both the hind legs of Balb/cA nude mice. Tumor‐bearing mice received 5‐bromo‐2′‐deoxyuridine (BrdU) continuously to label all proliferating (P) cells in the tumors. After administration of sodium borocaptate‐10B (BSH) or p‐boronophenylalanine‐10B (BPA), the tumors were irradiated with neutron beams. The tumors not treated with 10B‐compound were irradiated with neutron beams or γ‐rays. The tumors were then excised, minced and trypsinized. The tumor cell suspensions thus obtained were incubated with a cytokinesis blocker, and the micronucleus (MN) frequency in cells without BrdU labeling (=quiescent (Q) cells) was determined using immunofluorescence staining for BrdU. Meanwhile, 6 h after irradiation, tumor cell suspensions obtained in the same manner were used for determining the frequency of apoptosis in Q cells. The MN and apoptosis frequencies in total (P+Q) tumor cells were determined from the tumors that were not pretreated with BrdU. Without 10B‐carriers, in both tumors, the relative biological effectiveness of neutrons was greater in Q cells than in total cells, and larger for low than high cadmium ratio neutrons. With 10B‐carriers, the sensitivity was increased for each cell population, especially for total cells. BPA increased both frequencies for total cells more than BSH. Nevertheless, the sensitivity of Q cells treated with BPA was lower than that of BSH‐treated Q cells. These sensitization patterns in combination with 10B‐carriers were clearer in SASeo than in SAS/mp53 tumors. The p53 status of the tumor cells had the potential to affect the response to reactor neutron beam irradiation following 10B‐carrier administration.
机译:将经突变p53(SAS / mp53)或neo载体作为对照(SAS / neo)转染的人头颈部鳞状细胞癌细胞皮下接种到Balb / cA裸鼠的后腿。荷瘤小鼠连续接受5-溴2'-脱氧尿苷(BrdU)标记肿瘤中所有增殖(P)细胞。给予硼captate- 10 B(BSH)或对-boronophenylalanine- 10 B(BPA)钠后,用中子束照射肿瘤。未用 10 B-化合物治疗的肿瘤用中子束或γ射线辐照。然后切除肿瘤,切碎并用胰蛋白酶消化。将如此获得的肿瘤细胞悬液与胞质分裂阻滞剂一起温育,并且使用BrdU的免疫荧光染色来确定没有BrdU标记的细胞(=静止(Q)细胞)中的微核(MN)频率。同时,在照射后6小时,将以相同方式获得的肿瘤细胞悬液用于确定Q细胞的凋亡频率。从未经BrdU预处理的肿瘤中确定了全部(P + Q)肿瘤细胞的MN和凋亡频率。如果没有 10 B携带者,则在两种肿瘤中,Q细胞中子的相对生物学效力都比全细胞中大,而低镉比中子的中子相对生物学效力则更大。使用 10 B携带者,每个细胞群体(特别是总细胞)的灵敏度都提高了。与BSH相比,BPA增加两个频率的总细胞更多。但是,用BPA处理过的Q细胞的敏感性低于用BSH处理过的Q细胞。在SAS / neo中,这些增敏模式与 10 B携带者的结合比在SAS / mp53肿瘤中更清晰。施用 10 B载体后,肿瘤细胞的p53状态可能会影响对反应堆中子束辐照的反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号